Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04241757
Other study ID # IRBN432019/CHUSTE
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date September 17, 2019
Est. completion date November 19, 2021

Study information

Verified date June 2023
Source Centre Hospitalier Universitaire de Saint Etienne
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Existing resources to assist interpretation of ElectroCardioGram (ECG) in general practice provide specialized and comprehensive reading based on pathologies and ElectroCardioGram (ECG) signs rather than ElectroCardioGram (ECG) indications. Describing practices in general medicine could help prioritize the relevance of clinical and ECG signs for the general practitioner, enabling to adjust the reading given the context.


Description:

The primary objective of this study is to describe the clinical signs and ElectroCardioGram (ECG) in situations indicating an ElectroCardioGram (ECG) in general practice.


Recruitment information / eligibility

Status Terminated
Enrollment 888
Est. completion date November 19, 2021
Est. primary completion date October 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient consulting one of the generalist practitioner investigators - In doctor's office or at home, scheduled or not, - During normal surgery hours or out-of-hours service, - Whatever the reason for consultation, - Aged 18 years or older, - Having an indication of ElectroCardioGram (ECG) and/or request certificate of non-contra-indication to the practice of physical activity certificate of non-contra-indication to the practice of physical activity Exclusion Criteria: - ElectroCardioGram (ECG) not performed due to emergency context - Patient with cognitive impairment who cannot give consent to participate in the study and / or patient under guardianship

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
ElectroCardioGram (ECG)
Collection of results ElectroCardioGram (ECG).

Locations

Country Name City State
France Association CNGE IRMG Saint-Étienne

Sponsors (2)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Saint Etienne Association CNGE IRMG

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Description of clinical signs Prevalence of each clinical sign within each Electrocardiogram indication day 0
Primary Description of clinical signs ElectroCardioGram (ECG) sign Prevalence of each sign on the Electrocardiogram within each indication. day 0
Secondary Difficulties in carrying out the Electrocardiogram Duration of the Electrocardiogram (minutes) Measured by average duration of the ECG, prevalence of the difficulties of realization and interpretation mentioned by the investigators. Day 0
Secondary Initial management types Prevalence of initial management types (certificate, medication, addressing) at 1 month. Months 1
Secondary Diagnosis types Prevalence of diagnosis types at 1 month. Months 1